BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30880706)

  • 1. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
    Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
    Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
    Singh S; Singh M; Verma N; Sharma M; Pradhan P; Chauhan A; Jaiswal N; Chakrabarti A; Singh M
    Med Mycol; 2021 Feb; 59(2):139-148. PubMed ID: 32448907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections.
    Verma N; Singh S; Taneja S; Duseja A; Singh V; Dhiman RK; Chakrabarti A; Chawla YK
    Liver Int; 2019 Mar; 39(3):503-513. PubMed ID: 30276951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-β-D-glucan assay for invasive fungal infection in paediatric cancer patients.
    Gupta P; Ahmad A; Khare V; Kumar A; Banerjee G; Verma N; Singh M
    Mycoses; 2017 Apr; 60(4):234-240. PubMed ID: 27862370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people.
    White SK; Schmidt RL; Walker BS; Hanson KE
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009833. PubMed ID: 32693433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of serum human Galactomannan aspergillus antigen and 1,3-beta-D-glucan in immunocompromised patient suspected fungal infection.
    Susianti H; Parmadi L; Firani NK; Setyawan UA; Sartono TR
    J Clin Lab Anal; 2021 Jun; 35(6):e23806. PubMed ID: 33945177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-1,3-d-Glucan and Galactomannan as Biomarkers for the Detection of Invasive
    Forster J; Koc Ö; Koeppel MB; Hamprecht A; Kurzai O; Suerbaum S; Wagener J; Dichtl K
    J Clin Microbiol; 2022 Jan; 60(1):e0160721. PubMed ID: 34669454
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective Evaluation of Galactomannan and (1→3) β-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal Prophylaxis.
    Fisher BT; Westling T; Boge CLK; Zaoutis TE; Dvorak CC; Nieder M; Zerr DM; Wingard JR; Villaluna D; Esbenshade AJ; Alexander S; Gunn S; Wheat LJ; Sung L
    J Pediatric Infect Dis Soc; 2021 Sep; 10(8):864-871. PubMed ID: 34173659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study.
    Cento V; Alteri C; Mancini V; Gatti M; Lepera V; Mazza E; Moioli MC; Merli M; Colombo J; Orcese CA; Bielli A; Torri S; Gasparini LE; Vismara C; De Gasperi A; Brioschi P; Puoti M; Cairoli R; Lombardi G; Perno CF
    Mycoses; 2020 Dec; 63(12):1299-1310. PubMed ID: 32810888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-D-glucan for invasive fungal infection: Focus on cutoff levels.
    He S; Hang JP; Zhang L; Wang F; Zhang DC; Gong FH
    J Microbiol Immunol Infect; 2015 Aug; 48(4):351-61. PubMed ID: 25081986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of galactomannan and beta-d-glucan assays for the diagnosis of invasive aspergillosis in clinically suspected cases.
    Sarwar M; Gardezi SAH; Zaman G; Ikram A; Satti L; Khadim MT
    J Pak Med Assoc; 2020 Mar; 70(3):442-446. PubMed ID: 32207422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.
    Zheng F; Zha H; Yang D; Deng J; Zhang Z
    Mycopathologia; 2017 Apr; 182(3-4):331-338. PubMed ID: 27664106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of β-D-glucan for the diagnosis of invasive fungal infection in children with hematological malignancy.
    Guitard J; Tabone MD; Senghor Y; Cros C; Moissenet D; Markowicz K; Valin N; Leverger G; Hennequin C
    J Infect; 2016 Dec; 73(6):607-615. PubMed ID: 27452196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
    Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
    Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
    Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
    J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections.
    Rose SR; Vallabhajosyula S; Velez MG; Fedorko DP; VanRaden MJ; Gea-Banacloche JC; Lionakis MS
    J Infect; 2014 Sep; 69(3):278-83. PubMed ID: 24797077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.
    Metan G; Ağkuş C; Buldu H; Koç AN
    Infection; 2010 Jun; 38(3):217-21. PubMed ID: 20237947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two β-D-glucan assays for detecting invasive fungal diseases in immunocompromised patients.
    Song J; Kim S; Park J; Park Y; Kim HS
    Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115415. PubMed ID: 34082306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usage of 1,3-β-D-Glucan for Early Detection of Invasive Mycoses and Outcome Parameter in Immunocompromised Critically Ill Patients.
    Lahmer T; Held J; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
    Mycopathologia; 2016 Dec; 181(11-12):815-821. PubMed ID: 27619810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.